logo
  

Norsk Hydro Offers To Buy Polish Recycler Alumetal For EUR 232 Mln

Norwegian energy and aluminum company Norsk Hydro ASA (NHY,NHYDY.PK,NHYDY.PK) said that it has offered to buy the Polish recycler Alumetal for 68.4 PLN per share in cash, representing an aggregate equity purchase price of about 1.07 billion PLN or about 232 million euros.

The offer price represents a 4.7% premium over the closing price of the day prior to the announcement.

Norsk Hydro noted that the completion of the tender offer is subject to customary terms and conditions, including obtaining competition clearance and gaining control of a minimum of 66% of total shares outstanding.

Hydro said it has concluded an agreement with two members of the Alumetal Supervisory Board and all members of the Alumetal Management Board, in total holding about 39% of the company's shares, who have undertaken to submit subscriptions in the tender offer for all their shares at the offer price.

The subscription period for the tender offer is expected to commence on June 13, 2022 and expire on July 12, 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MTD Products Inc. is recalling 1,774 units of walk-behind self-propelled lawn mowers for potential risk of fire hazard, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the lawn mower can leak fuel when it is stored in the upright (vertical) storage position to pose a fire hazard. Nike Inc. announced its plans to exit the Russian market completely following Russia's ongoing war against Ukraine, reports said. The sportswear major, with more than 100 stores in the country, had suspended operations there in March. Earlier in March, while suspending operations temporarily, the company had said its customers that it couldn't guarantee product shipments. The U.S. Food and Drug Administration unveiled its action plan to advance drug development for rare neurodegenerative diseases, including Amyotrophic Lateral Sclerosis or ALS, in five years. The FDA plans specific actions such as regulatory science initiatives, enhancements to existing programs and new policy initiatives for the purpose. It will use public-private partnerships...
Follow RTT